Conexeu Sciences Stock (NASDAQ:CNXU)
Previous Close
$10.92
52W Range
$9.60 - $18.79
50D Avg
$12.77
200D Avg
$12.77
Market Cap
$214.65M
Avg Vol (3M)
$78.58K
Beta
-
Div Yield
-
CNXU Company Profile
Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.